Global Antimicrobial Susceptibility Testing Market Size study & Forecast, by Product Type (Manual Products, Consumables, Automated Products), by Method Type (ETEST, Disks Diffusion, Rapid Automation Method, Others), by End User (Hospitals & Diagnostic Lab

Global Antimicrobial Susceptibility Testing Market Size study & Forecast, by Product Type (Manual Products, Consumables, Automated Products), by Method Type (ETEST, Disks Diffusion, Rapid Automation Method, Others), by End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others) and Regional Analysis, 2023-2030

Global Antimicrobial Susceptibility Testing Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% during the forecast period 2023-2030. Antimicrobial Susceptibility Testing (AST) is a laboratory technique used to determine the effectiveness of antimicrobial agents (such as antibiotics) against specific microorganisms, typically bacteria or fungi. The primary goal of AST is to assist healthcare providers in selecting the most appropriate and effective antimicrobial treatment for infections. The key factors driving the market growth are the rising prevalence of multi-drug resistant organisms, increasing incidence of infectious diseases, and growing healthcare expenditure that anticipated to support the market growth during the forecast period 2023-2030.

Additionally, increased healthcare expenditure can support the growth of the Antimicrobial Susceptibility Testing (AST) Market. Higher healthcare expenditure allows for increased investment in research and development activities related to healthcare technologies, including AST. This can lead to the development of more advanced and efficient AST methods, technologies, and products. According to Statista, in 2019, the global health expenditure as a share of the GDP was 9.82% and the share reached 10.71% in 2022. As a result, the growing healthcare expenditure is anticipated to support the market growth over the projected period. Moreover, the increasing awareness initiatives for antimicrobial resistance and its control and development of manual and automated products are anticipated to create a lucrative opportunity for the market over the projected period. However, the high cost of automated AST systems & stringent government regulations stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antimicrobial Susceptibility Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising incidence of infectious diseases, growing technological advances, such as automation, improved testing methods, and rapid diagnostic techniques, enhanced efficiency and accuracy of antimicrobial susceptibility testing, and the presence of key market players. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the increase in healthcare-associated infections, coupled with the risk of antibiotic-resistant strains in hospital settings, growing awareness among healthcare professionals and the general public about the importance of antimicrobial susceptibility testing, and increasing prevalence of infectious diseases and the emergence of drug-resistant strains of bacteria.

Major market player included in this report are:
Accelerate Diagnostics, Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories, Inc.
Bruker
Danaher Corporation (Beckman Coulter)
F. Hoffmann-La Roche AG
HiMedia Laboratories Private Limited
Merck KGaA (MilliporeSigma)
Thermo Fisher Scientific Inc

Recent Developments in the Market:
 In May 2022, Qualigen Therapeutics revealed that NanoSynex Ltd, a firm with which Qualigen has recently finalized agreements to acquire a controlling interest, was highlighted at BioMed Israel. NanoSynex's groundbreaking technology aims to expedite antimicrobial susceptibility test results by a factor of six.

Global Antimicrobial Susceptibility Testing Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Product Type, Method Type, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Manual Products
Consumables
Automated Products
By Method Type:
ETEST
Disks Diffusion
Rapid Automation Method
Others
By End User:
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Others
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Accelerate Diagnostics, Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories, Inc.
Bruker
Danaher Corporation (Beckman Coulter)
F. Hoffmann-La Roche AG
HiMedia Laboratories Private Limited
Merck KGaA (MilliporeSigma)
Thermo Fisher Scientific Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.